The Insulin/IGF-I Axis in Diabetic Osteopathy

糖尿病骨病中的胰岛素/IGF-I 轴

基本信息

  • 批准号:
    8325294
  • 负责人:
  • 金额:
    $ 32.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-05-23 至 2016-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Type 1 diabetes mellitus (T1D) is associated with several disorders of skeletal health, including decreased bone mineral density (BMD) and an increased risk for osteoporosis and fragility fracture. Moreover, clinical evidence suggests that skeletal abnormalities in T1D result from the detrimental effects of T1D on bone formation. While BMD is typically not diminished in Type 2 diabetes mellitus (T2D), bone quality is impaired and fracture risk is increased. The shared as well as distinct features underlying diabetic osteopathy in T1D and T2D are not well understood at this time; however, studies have suggested that impaired insulin production, insulin action, insulin-like growth factor-I (IGF-I) action, as well as indirect effects of insulin to promote insulin-like growth factor-I (IGF-I) production, may be central events in promoting diabetic bone disease. Recent data from our laboratory examining animal models of diabetes have demonstrated that: 1) severe deficits in bone formation occur in the context of insulin-deficiency in mouse models of T1D; 2) normalization of systemic insulin levels stimulates new bone formation through RUNX2 and RUNX2 target genes in diabetic animals; and 3) insulin and IGF-I may signal via similar down-stream pathways to promote osteoblastogenesis. To clarify mechanisms by which insulin and/or IGF-I modulate osteogenesis, and how deficiencies or impaired signaling of each may contribute to diabetic osteopathy, we will examine through which signaling pathway(s) insulin regulates RUNX2 and RUNX2 target genes. We also will study mice generated in our laboratory with conditional knock-out of the insulin receptor (IR) in osteoblasts (OIRKO mice) in regards to in utero skeletal development, postnatal affects on skeletal growth and development, and de novo bone formation. Furthermore, we will dissect the specific roles of insulin and IGF-I and their cognate receptors in the osteoblastogenic process by comparing control osteoblasts to osteoblasts lacking the IR, the IGF-1 receptor (IGFR), or both the IR and IGFR in regards to insulin, IGF-I or insulin and IGF-I stimulated proliferation, differentiation, and osteogenic gene expression. To specify the roles that insulin and IGF-I may play in the pathogenesis and treatment of diabetic osteopathy, we will investigate the effects of diabetes on bone homeostasis and integrity in the osteoblast-specific insulin receptor knock-out (OIRKO) mouse, the IGFR knock-out (OIGFRKO) mouse, or the IR/IGFR double-knock out (DKO) mouse. We then will evaluate the impact of insulin or IGF-I therapy to affect bone integrity in the diabetic OIRKO, OIGFRKO, and DKO mouse. Finally, we will determine if FoxO transcription factors, major down-stream targets of insulin and IGF-I signaling, are integral to the diabetic bone phenotype. We will study the effects of osteoblast-specific deficiencies in FoxO1, FoxO3 and FoxO4 in STZ- induced diabetes as a way to preserve skeletal integrity in T1D. Together, these studies will provide critical mechanistic and pre-clinical information needed to better understand how corrections in insulin and/or IGF-I in diabetes may be beneficial in preventing and treating diabetic osteopathy. PUBLIC HEALTH RELEVANCE: Humans with Type 1 diabetes (T1D) and Type 2 diabetes (T2D) are susceptible to diabetic bone disease and are at increased risk for fracture. Despite the well- recognized increased risk of osteoporosis, fracture, and poor fracture healing that occurs with diabetes, how insulin or its homolog, insulin-like growth factor 1 (IGF-I), directly affects skeletal well-being in diabetes is poorly understood. This proposal is intended to better define the relative contributions of insulin and IGF-I to the molecular and cellular events involve in development of diabetic bone disease, as well as explore their therapeutic potential in preventing diabetic bone disease.
描述(由申请人提供):1型糖尿病(T1 D)与几种骨骼健康疾病相关,包括骨矿物质密度(BMD)降低和骨质疏松症和脆性骨折风险增加。此外,临床证据表明,T1 D中的骨骼异常是由T1 D对骨形成的不利影响引起的。虽然2型糖尿病(T2 D)的BMD通常不会降低,但骨质量受损,骨折风险增加。T1 D和T2 D糖尿病性骨病的共同特征和独特特征目前尚不清楚;然而,研究表明,胰岛素产生、胰岛素作用、胰岛素样生长因子-I(IGF-I)作用受损以及胰岛素促进胰岛素样生长因子-I(IGF-I)产生的间接作用可能是促进糖尿病性骨病的中心事件。我们实验室检查糖尿病动物模型的最新数据表明:1)在T1 D小鼠模型中,在胰岛素缺乏的背景下发生骨形成的严重缺陷; 2)全身胰岛素水平的正常化通过糖尿病动物中的RUNX 2和RUNX 2靶基因刺激新骨形成; 3)胰岛素和IGF-I可能通过类似的下游途径发出信号,以促进成骨细胞生成。为了阐明胰岛素和/或IGF-I调节成骨的机制,以及各自的缺陷或受损信号传导如何导致糖尿病骨病,我们将研究胰岛素通过哪些信号传导途径调节RUNX 2和RUNX 2靶基因。我们还将研究我们实验室中产生的成骨细胞胰岛素受体(IR)条件性敲除小鼠(OIRKO小鼠)在子宫内骨骼发育、出生后对骨骼生长和发育的影响以及从头骨形成方面的情况。此外,我们将通过比较对照成骨细胞与缺乏IR、IGF-1受体(IGFR)或IR和IGFR的成骨细胞在胰岛素、IGF-1或胰岛素和IGF-1刺激的增殖、分化和成骨基因表达方面的作用,来剖析胰岛素和IGF-1及其同源受体在成骨细胞生成过程中的具体作用。为了明确胰岛素和IGF-I在糖尿病性骨病的发病机制和治疗中可能发挥的作用,我们将在成骨细胞特异性胰岛素受体敲除(OIRKO)小鼠、IGFR敲除(OIGFRKO)小鼠或IR/IGFR双敲除(DKO)小鼠中研究糖尿病对骨稳态和骨完整性的影响。然后,我们将评估胰岛素或IGF-I治疗对糖尿病OIRKO、OIGFRKO和DKO小鼠骨完整性的影响。最后,我们将确定FoxO转录因子,胰岛素和IGF-I信号传导的主要下游靶点,是否是糖尿病骨表型的组成部分。我们将研究成骨细胞特异性缺陷FoxO 1、FoxO 3和FoxO 4在STZ诱导的糖尿病中的作用,作为保持T1 D骨骼完整性的一种方法。总之,这些研究将提供更好地了解糖尿病中胰岛素和/或IGF-I的校正如何有益于预防和治疗糖尿病骨病所需的关键机制和临床前信息。 公共卫生相关性:1型糖尿病(T1 D)和2型糖尿病(T2 D)患者易患糖尿病性骨病,骨折风险增加。尽管糖尿病引起的骨质疏松、骨折和骨折愈合不良的风险增加是众所周知的,但胰岛素或其同系物胰岛素样生长因子1(IGF-I)如何直接影响糖尿病中的骨骼健康仍知之甚少。该建议旨在更好地确定胰岛素和IGF-I对糖尿病骨病发生的分子和细胞事件的相对贡献,以及探索其在预防糖尿病骨病中的治疗潜力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John L Fowlkes其他文献

Early Developmental Changes in IGF-I, IGF-II, IGF Binding Protein-1, and IGF Binding Protein-3 Concentration in the Cerebrospinal Fluid of Children
  • DOI:
    10.1203/01.pdr.0000156369.62787.96
  • 发表时间:
    2005-07-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    R Clay Bunn;William D King;Margaret K Winkler;John L Fowlkes
  • 通讯作者:
    John L Fowlkes

John L Fowlkes的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John L Fowlkes', 18)}}的其他基金

Origins of Skeletal Fragility in Type 1 Diabetes
1 型糖尿病骨骼脆弱的起源
  • 批准号:
    10733855
  • 财政年份:
    2023
  • 资助金额:
    $ 32.41万
  • 项目类别:
The Insulin/IGF-I Axis in Diabetic Osteopathy
糖尿病骨病中的胰岛素/IGF-I 轴
  • 批准号:
    8637058
  • 财政年份:
    2012
  • 资助金额:
    $ 32.41万
  • 项目类别:
The Insulin/IGF-I Axis in Diabetic Osteopathy
糖尿病骨病中的胰岛素/IGF-I 轴
  • 批准号:
    8998113
  • 财政年份:
    2012
  • 资助金额:
    $ 32.41万
  • 项目类别:
The Insulin/IGF-I Axis in Diabetic Osteopathy
糖尿病骨病中的胰岛素/IGF-I 轴
  • 批准号:
    8472482
  • 财政年份:
    2012
  • 资助金额:
    $ 32.41万
  • 项目类别:
THE PHYSIOLOGY OF IGFBP DEGRADING PROTEINASES IN BONE
IGFBP 降解骨中蛋白酶的生理学
  • 批准号:
    7117279
  • 财政年份:
    1999
  • 资助金额:
    $ 32.41万
  • 项目类别:
THE PHYSIOLOGY OF IGFBP DEGRADING PROTEINASES IN BONE
IGFBP 降解骨中蛋白酶的生理学
  • 批准号:
    6177453
  • 财政年份:
    1999
  • 资助金额:
    $ 32.41万
  • 项目类别:
THE PHYSIOLOGY OF IGFBP DEGRADING PROTEINASES IN BONE
IGFBP 降解骨中蛋白酶的生理学
  • 批准号:
    7650176
  • 财政年份:
    1999
  • 资助金额:
    $ 32.41万
  • 项目类别:
THE PHYSIOLOGY OF IGFBP DEGRADING PROTEINASES IN BONE
IGFBP 降解骨中蛋白酶的生理学
  • 批准号:
    7462272
  • 财政年份:
    1999
  • 资助金额:
    $ 32.41万
  • 项目类别:
THE PHYSIOLOGY OF IGFBP DEGRADING PROTEINASES IN BONE
IGFBP 降解骨中蛋白酶的生理学
  • 批准号:
    6985097
  • 财政年份:
    1999
  • 资助金额:
    $ 32.41万
  • 项目类别:
THE PHYSIOLOGY OF IGFBP DEGRADING PROTEINASES IN BONE
IGFBP 降解骨中蛋白酶的生理学
  • 批准号:
    6866079
  • 财政年份:
    1999
  • 资助金额:
    $ 32.41万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 32.41万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 32.41万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 32.41万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 32.41万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 32.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 32.41万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 32.41万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 32.41万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 32.41万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 32.41万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了